Researchers at the University of Rochester Medical Center have developed a new imaging technique that could revolutionize how eye health and disease are assessed. The group is first to be able to make out individual cells at the back of the eye that are implicated in vision loss in diseases like glaucoma. They hope their new technique could prevent vision loss via earlier diagnosis and treatment for these diseases.
In a study highlighted in the Proceedings of the National Academy of Sciences, Ethan A. Rossi, Ph.D., assistant professor of Ophthalmology at the University of Pittsburgh School of Medicine, describes a new method to non-invasively image the human retina, a layer of cells at the back of the eye that are essential for vision. The group, led by David Williams, Ph.D., Dean for Research in Arts, Sciences, and Engineering and the William G. Allyn Chair for Medical Optics at the University of Rochester, was able to distinguish individual retinal ganglion cells (RGCs), which bear most of the responsibility of relaying visual information to the brain.
There has been a longstanding interest in imaging RGCs because their death causes vision loss in glaucoma, the second leading cause of acquired blindness worldwide. Despite great efforts, no one has successfully captured images of individual human RGCs, in part because they are nearly perfectly transparent.
This new approach might eventually allow us to detect the loss of single ganglion cells. The sooner we can catch the loss, the better our chances of halting disease and preventing vision loss.
Instead of imaging RGCs directly, glaucoma is currently diagnosed by assessing the thickness of the nerve fibers projecting from the RGCs to the brain. However, by the time a change is typically detected in the retinal nerve fiber thickness, a patient may have lost tens of thousands of RGCs or more.
“In principle, this new approach might eventually allow us to detect the loss of single ganglion cells,” said Williams. “The sooner we can catch the loss, the better our chances of halting disease and preventing vision loss.”
Rossi and his colleagues were able to see RGCs by modifying an existing technology – confocal adaptive optics scanning light ophthalmoscopy (AOSLO). They collected multiple images, varying the size and location of the detector they used to gather light scattered out of the retina for each image, and then combined those images. The technique, called multi-offset detection, was performed at the University of Rochester Medical Center in animals as well as volunteers with normal vision and patients with age-related macular degeneration.
While RGCs were the main focus of Rossi’s investigations, they are just one type of cell that can be imaged using this new technique. In age-related macular degeneration, cone photoreceptors that detect color and are important for central vision are the first to die. AOSLO has been used to image cones before, but these cells were difficult to see in areas near Drusen, fatty deposits that are the most common early sign of the disease. Using their multi-offset technique in age-related macular degeneration patients, Rossi was able to assess the health of cones near Drusen and in areas where the retina had been damaged.
“This technique offers the opportunity to evaluate many retinal features that have previously remained inaccessible to imaging in the living eye,” said Rossi. “Not only RGCs, but potentially other nearly transparent cell classes as well.”
Rossi and his colleagues warn that their study included a small number of volunteers and an even smaller number of age-related macular degeneration patients. More studies will be needed to improve the robustness of the technique before it can be widely used in the clinic. Rossi is now setting up his own laboratory at the University of Pittsburgh and plans to continue working with Williams’ group in studying this technique and its ability to detect changes in retinal cells over the course of retinal diseases.
[osd_subscribe categories=’eye-disease-detection’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “EYE DISEASE DETECTION”‘]
Receive an email update when we add a new EYE DISEASE DETECTION article.
The Latest on: Eye disease detection
[google_news title=”” keyword=”eye disease detection” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Eye disease detection
- Washington University wins $20M to create new tech to detect eye diseaseon February 20, 2024 at 4:00 pm
A team of professors at Washington University has been awarded $20 million in federal funding to develop a new device designed to scan for eye diseases. The project, led by Chao Zhou, professor of ...
- What Is That New Machine Your Eye Doctor Is Using And Why: Electroretinographyon February 19, 2024 at 10:13 am
It is crucial for early detection and diagnosis of eye diseases. Electroretinography provides objective and quantifiable assessments of visual function and retinal well-being. With the help of ...
- Beyond 30: Prioritising eye health for long-term vision wellnesson February 18, 2024 at 9:22 pm
By implementing preventive measures and scheduling regular checkups, individuals can safeguard their eyesight and enjoy clear vision well into their later years ...
- Deep learning shines a new light on Parkinson's detection through the eyeon February 18, 2024 at 5:23 pm
Study demonstrates the potential of deep learning algorithms to predict Parkinson's disease (PD) through retinal fundus imaging, offering a non-invasive, early diagnostic tool.
- Researchers begin to unlock prion disease’s mysteries with early markers in eyeon February 15, 2024 at 5:00 pm
Prion disease, the boogieman of dementia, may soon lose some of its terrifying mystique, as researchers begin to unlock the secrets of its onset and the signs of latent disease. The Florey Institute ...
- Freenome raises $254M for blood test for early detection of canceron February 15, 2024 at 5:28 am
Cancer 'liquid biopsy' test developer Freenome ups its fundraising take to $1.3 billion with investment from Roche, Quest and others ...
- Machine Learning and New Tech Lead the Way in Eye Careon February 14, 2024 at 7:52 am
In a groundbreaking survey published in the Journal of Optometry in 2022, it was revealed that a significant majority of optometrists, or 72%, believe that artificial intelligence (AI) will enhance ...
- From Retinal Health To Heart Disease Detection: The Future Of AIon February 6, 2024 at 10:48 pm
Dr Divya Rao, medical director of Remidio said integration of AI into fundus cameras has made it possible to "detect retinal anomalies that are precursors to cardiovascular conditions".
- Copycat eyedrops may be contaminated with drug-resistant bacteria, FDA warnson February 1, 2024 at 5:36 am
Related FDA warns to stop using eyedrops amid unsanitary manufacturing conditions Early detection, treatment of glaucoma may save vision Case study links tainted eye drops to vision loss months ...
via Bing News